rs1555617368
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001042492.3(NF1):c.4078C>T(p.Gln1360*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001042492.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26556299, 23913538) -
- -
The NF1 c.4078C>T (p.Gln1360*) variant causes the premature termination of NF1 protein synthesis. This variant has been reported in the published literature in individuals affected with neurofibromatosis 1 (PMID: 23913538 (2013)) and a gastrointestinal stromal tumor that showed loss of heterozygosity of the wild-type allele (PMID: 26556299 (2016)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Based on the available information, this variant is classified as pathogenic. -
Neurofibromatosis, type 1 Pathogenic:2
This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln1360*) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). This premature translational stop signal has been observed in individual(s) with clinical features of NF1-related conditions (PMID: 23913538, 26556299). ClinVar contains an entry for this variant (Variation ID: 480204). For these reasons, this variant has been classified as Pathogenic. -
- -
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Pathogenic:1
The p.Q1360* variant (also known as c.4078C>T), located in coding exon 30 of the NF1 gene, results from a C to T substitution at nucleotide position 4078. This changes the amino acid from a glutamine to a stop codon within coding exon 30. This alteration has been reported in 1 of 565 unrelated patients from the NF-France Network (Sabbagh A et al. Hum. Mutat., 2013 Nov;34:1510-8). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at